Search results
Intrinsic Eczema: Everything You Need to Know
Verywell Health via Yahoo News· 2 years agoIntrinsic eczema, a type of atopic dermatitis, is a chronic skin condition that causes itchy rashes. See pictures of intrinsic eczema and learn how to...
Sanofi's (SNY) Dupixent Gets EU Nod for Eczema in Young Kids
Zacks via Yahoo Finance· 1 year agoSanofi (SNY) and Regeneron's Dupixent becomes the first and only targeted medicine approved to treat...
Sanofi's Dupixent gets U.S. approval to treat eczema in young children
Reuters via Yahoo News· 2 years agoDupixent is now the first approved treatment for moderate-to-severe eczema in young children, Sanofi...
Treatments for Eczema
Health via Yahoo News· 6 months agoEczema (also known as dermatitis) is a condition that primarily affects the skin, causing dryness, itchiness, scaliness, rashes, and blisters. In some...
Sanofi (SNY) Atopic Dermatitis Drug Meets Goals in Phase II Study
Zacks via Yahoo Finance· 10 months agoSanofi SNY announced that the mid-stage study evaluating pipeline candidate amlitelimab for...
What Is Baby Eczema?
Health via Yahoo News· 9 months agoBaby eczema is an umbrella term for different types of dermatitis. Eczema can develop in infants as young as two months old. Most cases of eczema occur...
Eczema and the COVID-19 Vaccine: Is it Safe?
Verywell Health via Yahoo News· 1 year agoCOVID-19 vaccines are safe for people who have eczema, an itchy rash that is the most common type of atopic dermatitis. The COVID-19 vaccines available...
How to manage eczema – according to a dermatologist
The Telegraph via Yahoo News· 2 months agoThe condition can be uncomfortable and create a sense of social embarrassment among sufferers For the one in 10 adults who will develop eczema at some...
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
Zacks via Yahoo Finance· 1 year agoThis week, Sanofi SNY and partner Regeneron’s REGN blockbuster medicine, Dupixent succeeded in a...
Pharma Stock Roundup: FDA Nod to GSK's MMR Jab & SNY's Dupixent Expanded Use
Zacks via Yahoo Finance· 2 years agoEuropean Commission approves Roche's (RHHBY) Tecentriq for a new indication. FDA gives the nod to...